Literature DB >> 3515343

Alternative branch points are selected during splicing of a yeast pre-mRNA in mammalian and yeast extracts.

B Ruskin, C W Pikielny, M Rosbash, M R Green.   

Abstract

Pre-mRNA splicing in yeast and higher eukaryotes proceeds by similar pathways, in which a probable splicing intermediate and the excised intron are in a lariat configuration. To compare the pre-mRNA splicing mechanisms in yeast and higher eukaryotes, we have analyzed the RNA products resulting from in vitro processing of a yeast intron-containing pre-mRNA in HeLa cell and yeast extracts. In yeast, the RNA branch (2'-5' phosphodiester bond) of the RNA lariat forms at the third adenosine of the TACTAAC box in vivo and in vitro. In contrast, in the HeLa cell extract, the yeast pre-mRNA is accurately spliced, but the RNA lariats contain RNA branches located significantly closer to the 3' splice site than the TACTAAC box. In yeast, mutant pre-mRNAs that lack the TACTAAC box are not spliced in vivo or in vitro. However, these same mutant pre-mRNAs are accurately spliced in the HeLa cell extract. Therefore, although pre-mRNA splicing in yeast and higher eukaryotes proceeds by the same basic pathway, there are substantial differences in the specificity of the biochemical components that mediate the formation of the RNA processing products.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3515343      PMCID: PMC323222          DOI: 10.1073/pnas.83.7.2022

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Micro thin-layer techniques for rapid sequence analysis of 32P-labeled RNA: double digestion and pancreatic ribonuclease analyses.

Authors:  G Volckaert; W Fiers
Journal:  Anal Biochem       Date:  1977-11       Impact factor: 3.365

2.  Cleavage of 5' splice site and lariat formation are independent of 3' splice site in yeast mRNA splicing.

Authors:  B C Rymond; M Rosbash
Journal:  Nature       Date:  1985 Oct 24-30       Impact factor: 49.962

3.  Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro.

Authors:  B Ruskin; A R Krainer; T Maniatis; M R Green
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

4.  Lariat RNA's as intermediates and products in the splicing of messenger RNA precursors.

Authors:  R A Padgett; M M Konarska; P J Grabowski; S F Hardy; P A Sharp
Journal:  Science       Date:  1984-08-31       Impact factor: 47.728

5.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

6.  Polyadenylylated nuclear RNA contains branches.

Authors:  J C Wallace; M Edmonds
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Point mutations identify the conserved, intron-contained TACTAAC box as an essential splicing signal sequence in yeast.

Authors:  C J Langford; F J Klinz; C Donath; D Gallwitz
Journal:  Cell       Date:  1984-03       Impact factor: 41.582

9.  Yeast is unable to excise foreign intervening sequences from hybrid gene transcripts.

Authors:  C Langford; W Nellen; J Niessing; D Gallwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

10.  Evidence for an intron-contained sequence required for the splicing of yeast RNA polymerase II transcripts.

Authors:  C J Langford; D Gallwitz
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

View more
  21 in total

1.  Crystal structure of a model branchpoint-U2 snRNA duplex containing bulged adenosines.

Authors:  J A Berglund; M Rosbash; S C Schultz
Journal:  RNA       Date:  2001-05       Impact factor: 4.942

2.  The xylanase introns from Cryptococcus albidus are accurately spliced in transgenic tobacco plants.

Authors:  J F Laliberté; O Nicolas; S Durand; R Morosoli
Journal:  Plant Mol Biol       Date:  1992-02       Impact factor: 4.076

3.  Accurate and efficient pre-mRNA splicing in Drosophila cell-free extracts.

Authors:  D C Rio
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

4.  Limited functional equivalence of phylogenetic variation in small nuclear RNA: yeast U2 RNA with altered branchpoint complementarity inhibits splicing and produces a dominant lethal phenotype.

Authors:  L Miraglia; S Seiwert; A H Igel; M Ares
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

5.  Exon as well as intron sequences are cis-regulating elements for the mutually exclusive alternative splicing of the beta tropomyosin gene.

Authors:  D Libri; M Goux-Pelletan; E Brody; M Y Fiszman
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

6.  Interplay between U2 snRNP and 3' splice factor(s) for branch point selection on human beta-globin pre-mRNA.

Authors:  C Alibert; J Tazi; J Temsamani; P Jeanteur; C Brunel; G Cathala
Journal:  Nucleic Acids Res       Date:  1990-01-25       Impact factor: 16.971

7.  RNA splicing and intron turnover are greatly diminished by a mutant yeast branch point.

Authors:  A Jacquier; M Rosbash
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  The 5' splice site: phylogenetic evolution and variable geometry of association with U1RNA.

Authors:  M Jacob; H Gallinaro
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

9.  A new natural hGH variant--17.5 kd--produced by alternative splicing. An additional consensus sequence which might play a role in branchpoint selection.

Authors:  C M Lecomte; A Renard; J A Martial
Journal:  Nucleic Acids Res       Date:  1987-08-25       Impact factor: 16.971

10.  Effects on mRNA splicing of mutations in the 3' region of the Saccharomyces cerevisiae actin intron.

Authors:  L A Fouser; J D Friesen
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.